-
Symbol
-
KLRS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
1,300,000 shares
-
Security Ownership %
-
5.7%
Shares, Excluding Options vs Price
RTW Investments, LP ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)
17 Feb 2026 - RTW Investments, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,300,000 shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS).
This represents 5.7% ownership of the company.
This is the first filing by RTW INVESTMENTS, LP disclosing ownership of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.